Shared investments between research institutions and the government are essential for the health, prosperity and future of ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced a ...

Appoints Sam Raha as CEO and Mark S. Verratti as COO Effective April 30, 2025SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) - ...

SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and PATHOMIQ, Inc., a developer of artificial ...

SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and PATHOMIQ, Inc., a developer of artificial ...

Genetic testing company Myriad Genetics (NASDAQ:MYGN) will be reporting results tomorrow after market hours. Here’s what you need to know. Myriad Genetics beat analysts’ revenue expectations by 1.3% ...

Shares of NASDAQ:MYGN opened at $14.19 on Thursday. The firm has a 50 day moving average of $13.45 and a 200-day moving average of $19.53. The stock has a market capitalization of $1.29 billion, a ...

In Chicopee, Massachusetts, a multi-day delay of 40 tons of salt based de-icer mucked up the street clean up. Several city trucks were sent earlier this week to Albany, New York, to pick up tons ...

SALT LAKE CITY — It didn't take long for Salt Lake City's mayor to name a new police chief. Salt Lake City Mayor Erin Mendenhall on Thursday named Brian Redd, executive director of the Utah ...

SALT LAKE CITY, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, has been named on the Forbes list of ...

(MENAFN- GlobeNewsWire - Nasdaq) SALT LAKE CITY, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine ...